US2007264362A1PendingUtilityA1
Method and composition for treating ear inflammation caused by dry ear
Est. expiryMay 11, 2026(expired)· nominal 20-yr term from priority
A61K 36/76A61K 36/886
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating diseases and conditions associated with dry ear comprising topically applying to the ear canal of a subject that is suffering therefrom a liquid composition comprising an anti-irritant agent, a wound healing agent; and an anti-inflammatory agent dissolved in a polyhydroxy liquid solvent.
Claims
exact text as granted — not AI-modified1 . A method of treating diseases and conditions associated with dry ear or asteatosis which comprises topically applying to the ear canal of a subject that is suffering therefrom a liquid composition comprising:
(a) an anti-irritant agent; (b) a wound healing agent; and (c) an anti-inflammatory agent:
dissolved in a polyhydroxy liquid solvent.
2 . The method of claim 1 wherein said subject is a human.
3 . The method of claim 1 wherein said polyhydroxy solvent is a mixture of a glycol and a glycerin.
4 . The method of claim 3 wherein said polyhydroxy solvent is a mixture of butylene glycol and glycerin.
5 . The method of claim 1 wherein anti-irritant is an avenanthramide.
6 . The method of claim 1 wherein wound healing agent is selected from the group consisting of Aloe, alphabisolol, and a mixture thereof.
7 . The method of claim 1 wherein anti-inflammatory agent is selected from the group consisting of dipotassium glycyrrhizate and White Willow Bark Extract.
8 . The method of claim 1 wherein said composition further comprises a cationic surfactant.
9 . The method of claim 8 wherein said composition further comprises from about 0.5 to about 10%, by weight, of said agents (a), (b), and (c).
10 . The method of claim 1 wherein said liquid composition comprises from about 0.1 to about 5% of an anti-irritant agent, 0.01 to about 1% of a wound healing agent and 0.001 to about 1% of an anti-inflammatory agent.
11 . A composition for treating the diseases and conditions associated with dry ear which comprises;
(a) an anti-irritant agent; (b) a wound healing agent; and (c) an anti-inflammatory agent:
dissolved in a polyhydroxy liquid solvent.
12 . The composition of claim 11 wherein said subject is a human.
13 . The composition of claim 11 wherein said polyhydroxy solvent is a mixture of a glycol and a glycerin.
14 . The composition of claim 13 wherein said polyhydroxy solvent is a mixture of butylene glycol and glycerin.
15 . The composition of claim 11 wherein anti-irritant is an avenanthramide.
16 . The composition of claim 11 wherein wound healing agent is selected from the group consisting of Aloe, alphabisolol and a mixture thereof.
17 . The composition of claim 11 wherein anti-inflammatory agent is selected from the group consisting of dipotassium glycyrrhizate and White Willow Bark Extract.
18 . The composition of claim 11 wherein said composition further comprises a cationic surfactant.
19 . The composition of claim 18 wherein said composition further comprises from about 0.5 to about 10%, by weight, of said agents (a), (b), and (c).
20 . The composition of claim 11 wherein said liquid composition comprises
21 . The method of claim 1 wherein said liquid composition comprises from about 0.1 to about 5% of an anti-irritant agent, 0.01 to about 1% of a wound healing agent and 0.001 to about 1% of an anti-inflammatory agent.Join the waitlist — get patent alerts
Track US2007264362A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.